Abstract:The 2017 World Health Organization Fact Sheet highlights that coronary artery disease is the leading cause of death globally, responsible for approximately 30% of all deaths. In this context, machine learning (ML) technology is crucial in identifying coronary artery disease, thereby saving lives. ML algorithms can potentially analyze complex patterns and correlations within medical data, enabling early detection and accurate diagnosis of CAD. By leveraging ML technology, healthcare professionals can make informed decisions and implement timely interventions, ultimately leading to improved outcomes and potentially reducing the mortality rate associated with coronary artery disease. Machine learning algorithms create non-invasive, quick, accurate, and economical diagnoses. As a result, machine learning algorithms can be employed to supplement existing approaches or as a forerunner to them. This study shows how to use the CNN classifier and RNN based on the LSTM classifier in deep learning to attain targeted "risk" CAD categorization utilizing an evolving set of 450 cytokine biomarkers that could be used as suggestive solid predictive variables for treatment. The two used classifiers are based on these "45" different cytokine prediction characteristics. The best Area Under the Receiver Operating Characteristic curve (AUROC) score achieved is (0.98) for a confidence interval (CI) of 95; the classifier RNN-LSTM used "450" cytokine biomarkers had a great (AUROC) score of 0.99 with a confidence interval of 0.95 the percentage 95, the CNN model containing cytokines received the second best AUROC score (0.92). The RNN-LSTM classifier considerably beats the CNN classifier regarding AUROC scores, as evidenced by a p -value smaller than 7.48 obtained via an independent t -test. As large-scale initiatives to achieve early, rapid, reliable, inexpensive, and accessible individual identification of CAD risk gain traction, robust machine learning algorithms can now augment older methods such as angiography. Incorporating 65 new sensitive cytokine biomarkers can increase early detection even more. Investigating the novel involvement of cytokines in CAD could lead to better risk detection, disease mechanism discovery, and new therapy options.

Deep Learning of Dual Plasma Fingerprints for High-Performance Infection Classification.

Accurate COVID-19 Detection Using Full Blood Count Data and Machine Learning

Integrated System for On-Site Rapid and Safe Screening of COVID-19

Deep Learning-based Multi-Class COVID-19 Classification with X-ray Images

Pseudotargeted Metabolomic Fingerprinting and Deep Learning for Identification and Visualization of Common Pathogens

Clinical Applicable AI System Based on Deep Learning Algorithm for Differentiation of Pulmonary Infectious Disease

Texture-Based Classification to Overcome Uncertainty between COVID-19 and Viral Pneumonia Using Machine Learning and Deep Learning Techniques

Deep learning for predicting COVID-19 malignant progression

Weakly Supervised Deep Learning for COVID-19 Infection Detection and Classification from CT Images

Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease

Detection of COVID-19 Using Deep Learning Algorithms on Chest Radiographs

Deep feature fusion classification network (DFFCNet): Towards accurate diagnosis of COVID-19 using chest X-rays images

Advanced detection of coronary artery disease via deep learning analysis of plasma cytokine data

Deep diagnostic agent forest (DDAF): A deep learning pathogen recognition system for pneumonia based on CT

Development and Validation of a Deep Learning System for Ascites Cytopathology Interpretation

COVID-19 lung infection detection using deep learning with transfer learning and ResNet101 features extraction and selection

Development of a Machine Learning-Assisted Model for the Early Detection of Severe COVID-19 Cases Combining Blood Test and Quantitative Computed Tomography Parameters.

A non-enhanced CT-based deep learning diagnostic system for COVID-19 infection at high risk among lung cancer patients

A Deep Learning System to Screen Novel Coronavirus Disease 2019 Pneumonia

Deep learning for differentiating novel coronavirus pneumonia and influenza pneumonia

Non-NAT Definite Diagnosis Models of COVID-19 Based on Hematological Features